Company / SG&A Expense
InnovAge Holding Corp. SG&A Expense History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$122.1M
FY2025
5-year range
$101.7M / $132.3M
FY2021-FY2025
Trend
+9.6%
vs FY2024
Sector context
#124 of 152
Health Care
What the data says
InnovAge Holding Corp.'s sg&a expense of $122M is lower than 82% of companies in the Health Care sector (FY2025). SG&A Expense has fluctuated over the past 6 years, ranging from $58M in FY2020 to $132M in FY2021.
Based on SEC 10-K filings.
$122M in FY2025 with a 5-year CAGR of +15.9%.
Increased from $116M to $122M over the past 2 years.
Health Care sector context is included.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- +6.3%
- 5-Year CAGR
- +15.9%
- 10-Year CAGR
- -
Sector benchmark
Top 18% in Health CareTop 18% of 152This company $122.1M Sector average $182.7B
▼
-99.9% below sector average
Key checks
Key Insights
- 5-year CAGR of +15.9%, indicating consistent growth.
- In FY2025, sg&a expense increased 9.6% year-over-year.
- Ranks #124 out of 152 companies in the Health Care sector.
- Peak sg&a expense was recorded in FY2021.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $122.1M | +9.6% |
| FY2024 | $111.3M | -3.7% |
| FY2023 | $115.6M | +13.8% |
| FY2022 | $101.7M | -23.2% |
| FY2021 | $132.3M | +126.3% |
| FY2020 | $58.5M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026